EUVIMEDEUVIMED entdecken
Multizentrische Studie

Prognostic Factors in Sinonasal Cancers: A Multicenter Pooled Analysis

Milica Stefanovic iD, Alberto Hernando-Calvo, Jesus Brenes Castro, Shao Hui Huang, Jie Su, Brian O'Sullivan, Jolie Ringash, Isabel Linares Galiana, Alicia Lozano Borbalas, Beatriz Cirauqui Cirauqui, Ezra Hahn, Iris Teruel und 9 weitere

The Laryngoscope · 2026-01 · 136 (1) · 226-235

DOI: 10.1002/lary.70044 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Laryngoscope, online erschienen am 26.08.2025. Verfasst von Milica Stefanovic und 20 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Oncology Department, Institut Català D'oncologia L'hospitalet. Hauptthemen laut MEDLINE: Paranasal Sinus Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 72 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Sinonasal cancers (SNC) are heterogeneous diseases with different clinical behavior. We aimed to identify prognostic factors in non‐metastatic (M0)‐SNC.

Methods

Electronic health records from M0‐SNC patients treated with definitive surgery ± postoperative radiotherapy or chemoradiotherapy at two tertiary institutions were reviewed. p16 staining was performed in the squamous cell carcinoma (SCC) subset. Multivariable analysis (MVA) calculated the adjusted hazard ratio (aHR) for histology type (SCC as the comparator), T/N categories, and primary treatment modality for the risk of locoregional failure (LRF), distant metastasis (DM), and deaths.

Results

A total of 376 patients were eligible including 209 (56%) SCC (p16+: 35; p16−/untested: 157), 42 (11%) adenocarcinoma, 35 (9%) sinonasal undifferentiated carcinoma or sinonasal neuroendocrine tumors (SNUC/SNEC), 33 (9%) mucosal melanoma (MM), 30 (8%) esthesioneuroblastoma (ES), and 27 (7%) adenoid cystic carcinoma (ACC). MVA identified MM histology (aHR 2.03, 95% CI 21.23–3.33), older age (aHR 1.02; 95% CI: 1.00–1.03), T3–4 tumor (aHR 5.08, 95% CI 2.77–9.30), and nodal involvement (aHR: 2.15, 95% CI 1.46–3.16) carried higher mortality risk (all p < 0.05); MM (aHR 10.14, 95% CI 4.90–21.01), ACC (aHR 2.97, 95% CI 1.27–6.96), and SNUC/SNEC (aHR 6.80, 95% CI 3.30–14.01) histologies and T3–4 categories (vs. T1–2, HR 4.79, 95% CI 1.53–14.95) had higher DM risk; T3–4 (aHR 2.33, 95% CI 1.37–3.97) and nodal involvement (aHR 1.70, 95% CI 1.11–2.60) conveyed higher LRF risk while SNUC/SNEC histologies had a lower LRF risk (aHR 0.51, 95% CI 0.26–3.33).

Conclusions

Different SNC histology types exhibit distinct patterns of relapse and survival, highlighting the need for different management strategies. Level of Evidence 4.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Paranasal Sinus NeoplasmsHumansMaleFemaleMiddle AgedPrognosisAgedRetrospective StudiesCarcinoma, Squamous CellAdultAged, 80 and overNeoplasm Staging

Stichwörter der Autor:innen

chemotherapyhead and neck cancer treatmentradiotherapysinonasal cancersquamous cell carcinomatrimodality treatment

Autor:innen und Institutionen

  • Radiation Oncology Department, Institut Català D'oncologia L'hospitalet.
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Canada.
  • Medical Oncology Department, Institut Català d'Oncologia L'Hospitalet, Barcelona, Spain.
  • Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Canada.
  • Department of Biostatistics, Princess Margaret Cancer Centre, University of Toronto, Canada.
  • Department of Otolaryngology-Head & Neck Surgery, Princess Margaret Cancer Centre, University of Toronto, Canada.

ORCID-Profile: Milica Stefanovic, Jordi Marruecos Querol, David Paul Goldstein

Zitieren

APA

Stefanovic, M., Hernando-Calvo, A., Castro, J. B., Huang, S. H., Su, J., O'Sullivan, B., Ringash, J., Galiana, I. L., Borbalas, A. L., Cirauqui, B. C., Hahn, E., Teruel, I., de Almeida, J. R., Querol, J. M., Witterick, I. J., Rubió-Casadevall, J., Goldstein, D. P., Siu, L. L., Waldron, J., …, & Spreafico, A. (2026). Prognostic Factors in Sinonasal Cancers: A Multicenter Pooled Analysis. The Laryngoscope, 136(1), 226-235. https://doi.org/10.1002/lary.70044

Vancouver

Stefanovic M, Hernando-Calvo A, Castro JB, Huang SH, Su J, O'Sullivan B, et al. Prognostic Factors in Sinonasal Cancers: A Multicenter Pooled Analysis. The Laryngoscope. 2026;136(1):226-235. doi:10.1002/lary.70044

BibTeX
@article{Stefanovic2026,
  author = {Stefanovic, Milica and Hernando-Calvo, Alberto and Castro, Jesus Brenes and Huang, Shao Hui and Su, Jie and O'Sullivan, Brian and Ringash, Jolie and Galiana, Isabel Linares and Borbalas, Alicia Lozano and Cirauqui, Beatriz Cirauqui and Hahn, Ezra and Teruel, Iris and de Almeida, John R and Querol, Jordi Marruecos and Witterick, Ian J and Rubió-Casadevall, Jordi and Goldstein, David Paul and Siu, Lillian L and Waldron, John and Oliva, Marc and Spreafico, Anna},
  title = {Prognostic Factors in Sinonasal Cancers: A Multicenter Pooled Analysis},
  journal = {The Laryngoscope},
  year = {2026},
  volume = {136},
  number = {1},
  pages = {226--235},
  doi = {10.1002/lary.70044}
}
Kostenlos starten →